In vitro restoration of polyclonal hematopoiesis in a chronic myelogenous leukemia after in vitro treatment with 4- hydroperoxycyclophosphamide [PDF]
G Degliantoni+2 more
openalex +1 more source
New onset diabetes manifesting as diabetic ketoacidosis in a patient with chronic myelogenous leukemia treated with imatinib. [PDF]
Salimova D+4 more
europepmc +1 more source
Inhibition of casein kinase 2 induces cell death in tyrosine kinase inhibitor resistant chronic myelogenous leukemia cells. [PDF]
Mitrovský O+8 more
europepmc +1 more source
A neutrophil membrane marker reveals two groups of chronic myelogenous leukemia and its absence may be a marker of disease progression [PDF]
JI Gallin+6 more
openalex +1 more source
Impact of national volume-based procurement policy on drugs treating chronic Myelogenous Leukemia. [PDF]
Yang Z+7 more
europepmc +1 more source
Brassinin Induces Apoptosis, Autophagy, and Paraptosis via MAPK Signaling Pathway Activation in Chronic Myelogenous Leukemia Cells. [PDF]
Yang MH+6 more
europepmc +1 more source
Presence of erythroglycan on human K-562 chronic myelogenous leukemia-derived cells.
Salvatore J. Turco+2 more
openalex +1 more source
Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia. [PDF]
Sharma S+8 more
europepmc +1 more source
Pericardial Effusion Secondary to Nilotinib in an Elderly Patient With Chronic Myelogenous Leukemia. [PDF]
Arora G+4 more
europepmc +1 more source
Treatment of <i>JAK2</i> V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report. [PDF]
Zhu F, Wang H, Qiu L.
europepmc +1 more source